ALDER BIOPHARMACEUTICALS INC - FORM S-1/A - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - May 1, 2014

Attached files

file filename
EX-10.8 - COLLABORATION AND LICENSE AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex108.htm
EX-10.6 - 2014 EMPLOYEE STOCK PURCHASE PLAN - ALDER BIOPHARMACEUTICALS INCd657876dex106.htm
EX-10.9 - ADDENDUM NO. 1 TO COLLABORATION AND LICENSE AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex109.htm
EX-10.11 - LICENSE AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex1011.htm
EX-10.10 - MASTER SERVICES AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex1010.htm
EX-10.24 - MASTER PRODUCT DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex1024.htm
S-1/A - AMENDMENT NO. 2 TO FORM S-1 - ALDER BIOPHARMACEUTICALS INCd657876ds1a.htm
EX-10.25 - FIRST AMENDMENT TO MASTER PRODUCT DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT - ALDER BIOPHARMACEUTICALS INCd657876dex1025.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1/A of Alder BioPharmaceuticals, Inc. of our report dated March 17, 2014, except for the effects of the reverse stock split described in the last paragraph of Note 1 as to which the date is April 24, 2014, relating to the financial statements of Alder BioPharmaceuticals, Inc., which appear in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Seattle, Washington

May 1, 2014

ALDER BIOPHARMACEUTICALS INC Reports